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Introduction {#sec001}
============

Anterior cruciate ligament (**ACL**) rupture can be devastating and life changing, particularly in young adults, as there is a 78% risk of knee arthritis after ACL rupture that is not influenced by surgical treatment \[[@pone.0173810.ref001]\]. The incidence of ACL rupture is high; it is estimated at 33.3--36.9/100,000 person years \[[@pone.0173810.ref002],[@pone.0173810.ref003]\]. About 80,000 ACL graft surgeries are performed per year in the USA \[[@pone.0173810.ref004]\], with annual costs of approximately \$1 billion \[[@pone.0173810.ref004]\]. A non-contact mechanism explains most ACL ruptures, with rupture typically occurring during landing or pivoting movements \[[@pone.0173810.ref003]\]. Risk of contralateral rupture is also high at 11.8% of patients \[[@pone.0173810.ref005]\]. Physiological and anatomic factors, such as intercondylar notch shape and posterior tibial slope influence disease risk and risk of ACL rupture. Subsequent contralateral ACL rupture is more frequent in females \[[@pone.0173810.ref006]\]. Although the underlying mechanism has not been fully defined, it is widely accepted that ACL rupture is a complex disorder with both genetic and environmental contributions to disease risk \[[@pone.0173810.ref007]\]. Given the prevalence of ACL rupture in human beings and substantial morbidity associated with the condition, identification of individuals at risk of ACL rupture before they become patients would provide the opportunity to intervene, thereby reducing the overall incidence of ACL rupture, the number of surgical procedures performed, and costs to both the hospital and patient.

ACL rupture patients are twice as likely to have a close relative with ACL rupture, when compared with individuals without ACL rupture \[[@pone.0173810.ref008]\]. Family members of patients with bilateral ACL rupture are also at higher risk of ACL rupture \[[@pone.0173810.ref009]\]. Family history of ACL rupture and a young age substantially increases risk of both ACL graft and contralateral ACL rupture \[[@pone.0173810.ref010],[@pone.0173810.ref011]\]. This suggests that a substantial genetic contribution to ACL rupture exists, although heritability has not been formally estimated. Candidate gene studies have focused on ligament matrix constituents that could influence structural properties, and genes that influence extracellular matrix remodeling. Associations have been identified with a number of genes including the α1 chain of type I collagen (*COL1A1)*, the α1 chain of type V collagen (*COL5A1*) and the α1 chain of type 12 collagen (*COL12A1*) \[[@pone.0173810.ref012]--[@pone.0173810.ref015]\]. The *COL1A1* polymorphism is located at the binding site for the Sp1 transcription factor \[[@pone.0173810.ref012]\]. These associations may influence risk of other orthopaedic conditions, such as shoulder dislocation and Achilles tendon injury \[[@pone.0173810.ref012],[@pone.0173810.ref013]\]. Recently, interaction between the *COL5A1* and *COL12A1* variants has been confirmed \[[@pone.0173810.ref015]\]. In other candidate gene studies, association between ACL rupture and polymorphisms in matrix metalloproteinase genes has been identified \[[@pone.0173810.ref016]--[@pone.0173810.ref017]\], particularly association with a polymorphism in the promotor region of matrix metalloproteinase-3 (*MMP-3*, stromelysin-1) in athletes \[[@pone.0173810.ref016]\]. Associations between polymorphisms in vascular endothelial factor A (*VEGFA*) and kinase insert-domain receptor (*KDR*), genes involved in angiogenesis signaling have also been found \[[@pone.0173810.ref018]\]. Some of these associations are gender-specific \[[@pone.0173810.ref013],[@pone.0173810.ref014],[@pone.0173810.ref018]\].

In addition to human genetic studies, genome-wide association study (GWAS) has been undertaken in domestic dogs (*Canis lupus familiaris*) with ACL rupture. Spontaneous naturally occurring non-contact ACL rupture is common in domestic dogs \[[@pone.0173810.ref019]\]. Similar to human beings, familial (breed) susceptibility and second ACL ruptures are typical \[[@pone.0173810.ref019],[@pone.0173810.ref020]\]. While no animal model can perfectly mirror the biomechanics of the human knee, the canine knee joint has been established as a model for human knee pathology for several decades \[[@pone.0173810.ref021]\]. Dogs, like other animal models, are quadrupedal which alters weight-bearing, gait, and joint range of motion. However, the relative dimensions of the cruciate ligaments, menisci, and intercondylar notch are similar between dogs and humans. Additionally, studies have shown that, when compared to other large animal models, the canine ACL is most similar to humans with respect to cell density, blood vessel density, and cell shape \[[@pone.0173810.ref022]\].

The dog is also an important model organism for comparative genomic studies, because selective breeding has created distinct genetically isolated populations (breeds) with extensive linkage disequilibrium (LD) and haplotype blocks that are \~10 to 100 times longer than in humans \[[@pone.0173810.ref023],[@pone.0173810.ref024]\]. Consequently, the dog is an important translational animal model for genomic one medicine research. The most important risk factor for ACL rupture in dogs is genetic background (breed) \[[@pone.0173810.ref020]\]. Disease prevalence exceeds 5% in several breeds (incidence of \~5,000 cases/100,000 dog years), \~100-fold higher than humans, whereas other breeds, such as the Greyhound, experience a much lower disease incidence \[[@pone.0173810.ref002],[@pone.0173810.ref003],[@pone.0173810.ref020]\]. Heritability of canine ACL rupture has been estimated at 0.27 in the Newfoundland and 0.28 in the Boxer \[[@pone.0173810.ref025],[@pone.0173810.ref026]\]. Candidate gene research using SNP genotyping in dogs has also implicated genes that regulate extracellular matrix composition and ligament strength, including *COL1A1* and *COL5A1* as risk loci for the trait \[[@pone.0173810.ref027]\]. GWAS has shown that canine ACL rupture is a complex trait with loci on canine chromosomes (CFA) 1, 3, and 33 in the Newfoundland \[[@pone.0173810.ref028]\]. Association signals in the *SORCS2* and *SEMA5B* genes suggest neuronal signaling pathways may also influence risk of ACL rupture \[[@pone.0173810.ref028]\].

We present a GWAS in the domestic dog to discover additional candidate loci associated with ACL rupture. To take advantage of the LD structure in dogs, the GWAS was conducted in a single high-risk breed, the Labrador Retriever, the most common purebred dog in the USA. Prevalence of ACL rupture in this breed is 5.79% \[[@pone.0173810.ref020]\]. The GWAS identified 99 candidate loci that influence risk of ACL rupture. A SNP on CFA 24 was significantly associated with ACL rupture. Pathway analysis implicated c-type lectins, such as aggrecan, in the disease pathogenesis.

Materials and methods {#sec002}
=====================

Ethics statement {#sec003}
----------------

All procedures were performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and the American Veterinary Medical Association and with approval from the Animal Care Committee of the University of Wisconsin-Madison (protocol \#V1070). Informed consent of each owner was obtained before participation in the study.

Canine samples and phenotyping {#sec004}
------------------------------

DNA was isolated from client-owned Labrador Retrievers using blood or saliva collection swabs. A four-generation pedigree was collected from each dog to ensure purebred status and identify siblings, which were excluded from the GWAS. Each dog underwent an orthopaedic examination that included assessment of knee stability \[[@pone.0173810.ref029]\]. Radiographs of the affected knee(s) were also assessed in cases. In addition, lateral weight-bearing knee radiographs were made to screen phenotype-negative control dogs. While it is not possible to identify the cruciate ligaments radiographically in the dog, compression of the infrapatellar fat pad in the knee by synovial effusion and knee osteophytosis are degenerative changes typically associated with ACL rupture \[[@pone.0173810.ref030]\]. Dogs were considered cases if anterior translation of the tibia relative to the femur was detected clinically and radiographic signs were consistent with ACL rupture. Labrador Retrievers ≥8 years of age have \~6% chance of developing ACL rupture \[[@pone.0173810.ref020],[@pone.0173810.ref031]\]. Therefore, control dogs were ≥8 years of age with a normal orthopaedic clinical exam and normal knee radiographs.

Genome-wide association {#sec005}
-----------------------

Genome-wide SNP genotyping was performed in 98 cases and 139 controls using the Illumina CanineHD BeadChip, which genotypes 173,662 SNPs evenly spaced across the genome. Data underwent quality control filtering using PLINK \[[@pone.0173810.ref032]\]. All samples had a genotyping call rate of ≥95%. 49,859 SNPs were excluded because minor allele frequency (MAF) was ≤0.05 and 7,468 SNPs were excluded because of a low genotyping rate (≤95%). 153 SNPs were excluded because of deviation from Hardy-Weinberg equilibrium at *P*\<1E-07. 118,992 SNPs were used for further analysis.

To account for ancestral population structure and family relatedness in the study dogs, single marker linear mixed model (LMM) analysis was performed using GCTA (Genome-wide Complex Trait Analysis) \[[@pone.0173810.ref033]\] and GEMMA (Genome-wide Efficient Mixed Model Association) \[[@pone.0173810.ref034]\], software tools optimized for complex trait GWAS. Penalized Unified Multiple-locus Association (PUMA), in which all SNPs are analyzed together, was also used to aid detection of weaker associations often found in complex traits \[[@pone.0173810.ref035]\]. We used logistic regression and a 2D-MCP penalty for this analysis \[[@pone.0173810.ref036]\]. In the PUMA analysis, the first 20 eigenvectors were used as covariates in the association analysis to correct for population structure. Eigenvectors were obtained by principal component analysis using GCTA. Because neutering has a significant effect on risk of ACL rupture \[[@pone.0173810.ref020],[@pone.0173810.ref037]\], it was included as a covariate with the GEMMA, GCTA, and PUMA analyses.

Genome-wide significance {#sec006}
------------------------

We defined genome-wide significance using permutation testing. Use of a Bonferroni correction for the number of SNPs tested is too conservative in dog breeds, as extensive LD means that SNPs are often inherited in haplotype blocks \[[@pone.0173810.ref024]\]. We defined genome-wide significance by randomly permuting the phenotypes and re-running the association analysis 1,000 times. Genome-wide significance was defined by identifying the 5% quantile of the set of minimum *P*-values from the GWAS permutations. Additionally, we estimated the number of haplotype blocks in the Labrador Retriever SNP data using PLINK \[[@pone.0173810.ref032]\], with LD windows of 500kb, 1Mb, and 5Mb and used the number of haplotype blocks to estimate genome-wide significance by Bonferroni correction of *P*\<0.05. To facilitate further dissection of genetic variants associated with the ACL phenotype, we also identified a larger set of candidate ACL rupture regions at *P*\<5E-04 \[[@pone.0173810.ref038]\]. Although some of the regions included may not be true associations, this would likely weaken rather than strengthen the gene set and pathway analyses, leading to false negatives rather than false positives \[[@pone.0173810.ref038]\].

Defining associated loci in the genome {#sec007}
--------------------------------------

Linkage-disequilibrium (LD) clumping using PLINK \[[@pone.0173810.ref032]\] was used to define regions of association with the ACL rupture trait from the GWAS results. LD clumping defined regions around SNPs associated at *P*\<5E-04 within 1 Mb of the index SNP (r^2^\>0.8 and *P*\<0.01). We also used GCTA to estimate in-breeding coefficient and the amount of phenotypic variance explained by the associated loci, which were defined as SNPs with r^2^\>0.2 within 5Mb of the peak SNP in each locus \[[@pone.0173810.ref033],[@pone.0173810.ref038],[@pone.0173810.ref039]\].

For complex trait GWAS with a large number of risk loci, sites that are not discovered are expected to have smaller effect sizes in a second generation GWAS, because those with larger effect sizes will have been identified in the first round of GWAS \[[@pone.0173810.ref040]\]. To estimate the number of risk loci that are likely associated with ACL rupture, we used INPower \[[@pone.0173810.ref040]\]. Odds ratios were corrected for the winner's curse before INPower analysis was performed \[[@pone.0173810.ref040],[@pone.0173810.ref041]\].

Genetic risk score computation {#sec008}
------------------------------

Two approaches were used to calculate the genetic risk scores (GRS), a simple risk alleles count method (cGRS) and a weighted method (wGRS) \[[@pone.0173810.ref042]\]. The wGRS weights each risk allele by the logarithm odds ratio (Log(OR)) for that allele. The wGRS is a linear combination of the number of risk alleles weighted by the Log(OR) as coefficients \[[@pone.0173810.ref042]\]. The Mann-Whitney U test was used to compare cGRS scores for each LMM in case and control groups. To estimate the total risk captured by the genetic risk scoring for each LMM, we calculated the odds ratios according to the wGRS quartiles \[[@pone.0173810.ref042]\]. We also measured the discriminative power attributable to the GRS by plotting receiver operating characteristic (ROC) curves and calculated the area under the curve (AUC) for the Labrador Retriever case and control dogs. AUC 95% confidence intervals were calculated using 2000 stratified bootstrap replicates. An R software package (pROC) was used for these analyses \[[@pone.0173810.ref043]\].

Pathway analysis {#sec009}
----------------

Pathway analysis was performed with two methods. DAVID \[[@pone.0173810.ref044]\] analyses were run on the ACL rupture loci identified from our GWAS. ACL rupture loci were transposed to CanFam 3.1 coordinates (genome.ucsc.edu/cgi-bin/hgLiftOver) with 500kb flanks added to the start and end, gene size correction turned on, and stringency set to high. A list of genes from the LiftOver coordinates was then analyzed. Probability values were evaluated after Benjamini correction with DAVID.

Pathway analysis with INRICH was performed on canFam2 intervals using a map file lifted over from the canFam3.1 Broad Improved Canine Annotation catalog (UCSC Genome Browser) \[[@pone.0173810.ref045]\]. We used 1,000,000 permutations matched for region size, SNP density, and gene number. INRICH reports significance for each gene set and the experiment-wide significance, correcting for the number of gene sets (*P*~corr~). We considered *P*~corr~\<0.05 to be significant \[[@pone.0173810.ref038]\]. We tested gene sets from the KEGG (Kyoto Encyclopedia of Genes and Genomes), Gene Ontology, and MSigDB (Molecular Signatures Database).

Heritability estimation {#sec010}
-----------------------

Genomic heritability was estimated from SNPs using the BGLR statistical package \[[@pone.0173810.ref046]\]. SNPs with missing genotypes were filtered out using PLINK \[[@pone.0173810.ref032]\]. Heritability estimation was performed using 99,103 SNPs. A genomic best linear unbiased prediction (GBLUP) model was fitted using a SNP-derived genomic relationship matrix, which is equivalent to a non-parametric reproducing kernel Hilbert spaces (RKHS) method \[[@pone.0173810.ref046]\]. Narrow sense genetic heritability was also estimated using a data matrix prepared from pedigrees. To fit the model, 30,000 iterations of the Gibbs sampler were used with burn-in of 5,000 iterations. A correction factor was used to transform the heritability estimate on the observed scale from the regression model to the liability scale for a binary trait \[[@pone.0173810.ref047]\] and a population prevalence of 0.0579 \[[@pone.0173810.ref020]\] was used for this correction.

Results {#sec011}
=======

GWAS population of Labrador Retrievers {#sec012}
--------------------------------------

We genotyped 237 Labrador Retrievers using the Illumina CanineHD BeadChip. All dogs had individual call rates of \>95%. The final dataset contained 118,992 SNPs from 98 cases and 139 phenotype-negative controls. Median inbreeding coefficient was 0.025 ([Fig 1](#pone.0173810.g001){ref-type="fig"}). The ratio of females to males in the case and control groups was 0.92 and 0.83 respectively. Of the 114 females, 99 were ovariohysterectomized (0.87). Of the 123 males, 96 were castrated (0.78). Neutered animals were distributed similarly among case and control groups (χ^2^ = 0.223, *P* = 0.6368). Mean age of the dogs in the case and control groups was 6.0±2.5 years and 10.4±1.7 years, respectively, and was significantly different (*P*\<0.0001).

![The Labrador Retriever is a dog breed with a relatively low amount of inbreeding.\
Whiskers represent the standard error of the mean for each analysis method (n = 237 dogs).](pone.0173810.g001){#pone.0173810.g001}

GWAS identifies 99 regions associated with anterior cruciate ligament rupture {#sec013}
-----------------------------------------------------------------------------

We tested for association between ACL rupture and SNPs with a MAF \>0.05 in the Labrador Retriever breed, controlling for cryptic relatedness and population structure using linear mixed model (LMM) analysis with three approaches, including a penalized multiple regression method for improved detection of weak associations. We identified all SNPS with either significant association based on analysis of 1,000 random phenotype permutations to define genome-wide significance (*P*\<1.549E-06 for GCTA, *P*\<6.097E-07 for GEMMA and *P*\<4.35E-07 for PUMA) or suggestive association (*P*\<5E-04; [Fig 2](#pone.0173810.g002){ref-type="fig"}; [Methods](#sec002){ref-type="sec"}) and defined regions of association through linkage disequilibrium ([Table 1](#pone.0173810.t001){ref-type="table"}, [S1 Table](#pone.0173810.s002){ref-type="supplementary-material"}). Control dogs were considered phenotype-negative because of the selection criteria used for recruitment. We identified 21,713, 21,754, and 21,861 haplotype blocks in the Labrador Retriever genome with LD windows of 5Mb, 1Mb, and 5kb respectively, yielding a genome-wide significance estimate of *P*\<2.29E-06 to *P*\<2.30E-06.

![Linear mixed model GWAS corrects for population structure and identifies 99 ACL associated loci explaining a large proportion of phenotypic variance.\
For each linear mixed model (LMM), the QQ plots show no evidence of population stratification relative to the expected distribution. Permutation testing with each model determined genome-wide significance at (**a**) *P*\<3.63E-7 for GCTA (Genome-wide Complex Trait Analysis) \[[@pone.0173810.ref033]\], λ = 0.987 (**b**) *P*\<6.097E-7 for GEMMA (Genome-wide Efficient Mixed Model Association) \[[@pone.0173810.ref034]\], λ = 0.994 and (**c**) *P*\<4.01E-7 for PUMA (Penalized Unified Multiple-locus Association) \[[@pone.0173810.ref035]\], λ = 1.012. The plots represent analysis of 118,992 SNPs from 98 cases and 139 phenotype-negative controls. (**d**) With GCTA, 36 loci have *P*\<5E-4, with the most significant locus located in CFA 24, which did not meet genome-wide significance defined by minimum p-values from permutation testing. (**e**) With GEMMA, 47 loci have *P*\<5E-4, with the locus on CFA 24 meeting genome-wide significance defined by minimum p-values from permutation testing. (**f**) With PUMA, 65 loci were significant at *P*\<5E-4 and the locus on CFA 24 exceeded genome-wide significance defined by minimum p-values from permutation testing. The single SNP that met genome-wide significance lies within the gene *PPP1R16B*.](pone.0173810.g002){#pone.0173810.g002}

10.1371/journal.pone.0173810.t001

###### ACL rupture associated loci identified by GWAS in the Labrador Retriever, a dog breed with a high disease prevalence.

![](pone.0173810.t001){#pone.0173810.t001g}

  SNP               Chr   Position   *P*        LMM     Risk allele   f(A)   f(U)   OR     Region start-end     Size (kb)   Genes
  ----------------- ----- ---------- ---------- ------- ------------- ------ ------ ------ -------------------- ----------- ---------------------------------------------------------------------------------------------------------------------------------------------------
  BICF2G630500368   24    30241088   2.76E-07   1,2,3   G             0.83   0.66   2.56   30241088--30245795   5           *BPI*, *LBP*, *RALGAPB*, *SLC32A1*, *ADIG*, *ACTR5*, *PPP1R16B*, *FAM83D*, *DHX35*
  BICF2P1121006     18    54279578   1.11E-05   1,2,3   A             0.63   0.42   2.28   No LD                            Many (40 genes)
  BICF2S2356299     27    30557856   2.21E-05   2,3     A             0.43   0.27   2.03   No LD                            *AEBP2*, *PLEKHA5*
  BICF2P483191      29    21601273   2.31E-05   1,2,3   C             0.73   0.51   2.54   No LD                            C29H8orf34, *SULF1*, *SLCO5A1*
  BICF2P50610       11    32270617   2.75E-05   3       A             0.29   0.19   1.7    31939564--32270617   331         C11H9orf123, *PTPRD*
  BICF2P890246      9     53427907   3.23E-05   1,2     A             0.16   0.36   2.99   53427907--53432248   4           Many (20 genes)
  BICF2S23324965    6     14077648   3.36E-05   3       G             0.68   0.60   1.42   14077648--14092057   14          *TRRAP*, *TMEM130*, *NPTX2*, *BAIAP2L1*, *BRI3*, *TECPR1*, *LMTK2*, *PMS2*, *EIF2AK1*, *ANKRD61*, *USP42*, *CYTH3*
  BICF2P544126      24    29772193   4.09E-05   3       G             0.94   0.87   2.28   29772193--29794411   22          *CTNNBL1*, *VSTM2L*, *TTI1*, *RPRD1B*, *TGM2*, *KIAA1755*, *BPI*, *LBP*, *RALGAPB*, *ADIG*, *SLC32A1*, *ACTR5*, *PPP1R16B*, *FAM83D*
  BICF2P526639      27    39217437   4.12E-05   2,3     G             0.23   0.12   2.18   39211186--39217437   6           *KLRD1*, *GABARAPL1*, *TMEM52B*, *OLR1*, *CLEC7A*, *CLEC1B*, *CLEC12B*, *CLEC12A*, *CLEC2B*, *KLRF1*, *CD69*, *CLEC2D*, *KLRB1*
  BICF2P1462185     20    15053718   4.89E-05   3       A             0.85   0.74   1.90   14838270--15053718   215         *EDEM1*, *ARL8B*
  BICF2P1208798     9     12671217   5.49E-05   1,2     G             0.56   0.36   2.27   No LD                            Many (20 genes)
  BICF2G630175389   4     84260906   5.87E-05   1,2     A             0.83   0.68   2.28   No LD                            *CDH10*
  BICF2S24415473    3     86974042   7.07E-05   1,2     G             0.40   0.26   1.97   86948527--86974042   26          *STIM2*, *TBC1D19*, *CCKAR*, *RBPJ*, *SEL1L3*
  BICF2G630412697   30    3126573    7.22E-05   1,3     G             0.96   0.86   4.23   No LD                            *OR4K2*, *OR4K1*, *ORFN5*
  BICF2P498515      6     75848537   7.89E-05   1,2,3   A             0.16   0.06   3.11   No LD                            *LRRIQ3*
  BICF2P792911      26    22894961   8.55--05   1,2,3   G             0.44   0.27   2.14   No LD                            *ADRBK2*, *MYO18B*, *SEZ6L*, *ASPHD2*, *HPS4*, *SRRD*, *TFP11*, *TPST2*, *CRYBB1*, *CRBA4*
  BICF2G630810143   6     11130832   9.46E-05   3       A             0.44   0.32   1.72   11130832--11177149   46          *UPK3B*, *LRWD1*, *ALKBH4*, *ORAI2*, *PRKRIP1*, *SH2B2*, *CUX1*, *MYL10*, *RABL5*, *FIS1*, *ZNHIT1*, *PLOD3*
  BICF2P564273      3     55250188   1.07E-04   1,2,3   A             0.70   0.52   2.16   No LD                            *ACAN*, *HAPLN3*, *MFGE8*, *ABHD2*, *RLBP1*, *FANCI*, *POLG*, *RHCG*, *TICRR*, C3H15orf38, *KIF7*, *PLIN1*, *PEX11A*, *WDR93*, *AMPN*, C3H15orf38
  TIGRP2P297337     22    58201452   1.08E-04   1,2,3   A             0.44   0.27   2.2    No LD                            *EFNB2*, *ARGLU1*
  BICF2G630658881   21    7582214    1.09E-04   1,2,3   G             0.49   0.32   2.12   7581714--8383209     800         *JRKL*, *CCDC82*, *MAML2*, *MTMR2*, *CEP57*, *FAM76B*, *SESN3*

**Note**: OR (odds ratio) calculated from PLINK \[[@pone.0173810.ref032]\]. LMM Linear mixed model 1 --GCTA \[[@pone.0173810.ref033]\], 2 --GEMMA \[[@pone.0173810.ref034]\], 3 --PUMA \[[@pone.0173810.ref035]\]. F(A) and F(U) represent the frequency of the risk allele in case and control dogs, respectively. Data represent the twenty most significant loci of 99 associations with canine ACL rupture. SNP position and genomic regions are based on canFam2. Genes lists were derived from the SNP locus or LD block with 500kb flanking regions after liftover to canFam 3.1.

With the Labrador Retriever breed, associated regions (*P*\<5E-04) explained approximately half of the phenotypic variance in the ACL rupture trait ([Fig 3](#pone.0173810.g003){ref-type="fig"}). For GCTA, 36 loci in 72.7Mb of the genome explained 48.09% of the phenotypic variance. For GEMMA, 47 loci in 82.7Mb of the genome explained 55.88% of the phenotypic variance. For PUMA, 65 loci in 86.58Mb of the genome explained 50.28% of the phenotypic variance in the ACL rupture trait.

![Phenotype variance was explained to a large degree by the associated genomic loci.\
Loci identified by linear mixed model (LMM) analysis were broadly defined as SNPs with r^2^\>0.5 within 5Mb of the peak SNP. (**a**) For GCTA, 36 loci in 72.7Mb of the genome explained 48.09% of the phenotypic variance. (**b**) For GEMMA, 47 loci in 82.7Mb of the genome explained 55.88% of the phenotypic variance. (**c**) For PUMA, 65 loci in 86.58Mb of the genome explained 50.28% of the phenotypic variance in the ACL rupture trait. Whiskers represent the standard error of the mean.](pone.0173810.g003){#pone.0173810.g003}

We identified 129 SNPs associated with canine ACL rupture. Using LD clumping, we found that these SNPs reside in 99 loci. Two of these regions were located in uncharacterized or non-coding regions of the genome. A SNP on CFA24 met genome-wide significance for LMM association analysis with GEMMA (*P* = 6.10E-07) and PUMA (*P* = 2.77E-07), but not GCTA (*P* = 3.63E-06). This SNP resides in a 5kb haplotype block with one other SNP. Nine genes are located within the locus defined by 500kb flanking regions including bactericidal/permeability-increased protein (*BPI*), lipopolysaccharide binding protein (*LBP*), Ral GTPase activation protein beta subunit (*RALGAPB*), adipogenin (*ADIG*), solute carrier family 32, member 1 (*SLC32A1*), ARP5 actin-related protein 5 (*ACTR5*), protein phosphatase 1, regulatory subunit 16B (*PPP1R16B*), family with sequence similarity 83, member D (*FAM83D*), and DEAH (Asp-Glu-Ala-His) box polypeptide 35 (*DHX35*). Although many risk loci contained large numbers of genes, two loci did not ([Table 1](#pone.0173810.t001){ref-type="table"}, [S1 Table](#pone.0173810.s002){ref-type="supplementary-material"}), suggesting these SNPs are associated with mutations affecting gene expression (rSNPs).

Power analysis of our GWAS data set using INPower estimates that 172 loci explain the genetic contribution to ACL rupture in the Labrador Retriever ([S2 Table](#pone.0173810.s003){ref-type="supplementary-material"}). INPower estimates that in a future GWAS, large numbers of dogs will be needed for discovery of future loci (\>1,500) ([S3 Table](#pone.0173810.s004){ref-type="supplementary-material"}).

Risk loci clearly distinguish ACL rupture cases from controls {#sec014}
-------------------------------------------------------------

To evaluate the cumulative effects of associated ACL rupture risk loci, we used a genetic risk scoring approach using a simple allele count (cGRS) or a weighted approach (wGRS). We found significant differences in the number of risk alleles in cases and controls for GCTA (*P*\<2.2E-16), GEMMA (*P*\<2.2E-16), and PUMA (*P*\<2.2E-16) ([Table 2](#pone.0173810.t002){ref-type="table"}), with a shift to increased numbers of risk alleles in the cases ([Fig 4](#pone.0173810.g004){ref-type="fig"}). When the odds ratios according to the wGRS quartiles for each LMM were calculated, there was a significant increase in ACL rupture odds ratios with increasing wGRS quartile for all three LMM, using the first wGRS quartile as a reference ([Fig 4](#pone.0173810.g004){ref-type="fig"}, [S1 Fig](#pone.0173810.s001){ref-type="supplementary-material"}).

10.1371/journal.pone.0173810.t002

###### Genetic risk scoring in ACL rupture case and control Labrador Retriever dogs using GWAS associated SNPs from linear mixed model analysis.

![](pone.0173810.t002){#pone.0173810.t002g}

  LMM     Number of Risk alleles   Significance   
  ------- ------------------------ -------------- --------------
  GCTA    24 (16, 40)              35 (24, 43)    *P*\<2.2E-16
  GEMMA   33 (22, 43)              45 (29, 55)    *P*\<2.2E-16
  PUMA    62 (37, 84)              77 (56, 99)    *P*\<2.2E-16

**Note**: Data represent median (range) for allele counting (cGRS) \[[@pone.0173810.ref051]\]. LMM Linear mixed models used were GCTA \[[@pone.0173810.ref033]\], GEMMA \[[@pone.0173810.ref034]\], PUMA \[[@pone.0173810.ref035]\]. The Mann-Whitney U test was used to determine significance.

![Genetic risk scoring \[[@pone.0173810.ref042]\] using GWAS associated loci from linear mixed model analysis with GEMMA segregates ACL rupture disease risk in case and control Labrador Retriever dogs.\
(**a**) Distribution of the number of ACL rupture risk loci in case and control groups of Labrador Retriever dogs. The number of risk alleles in cases and controls is significantly different (*P*\<2.2E-16) (**b**) ACL rupture odds ratios of weighted genetic risk scores (wGRS) relative to the first quartile. Vertical bars represent the 95% confidence intervals. \* Odds ratio is significantly different from the reference first quartile.](pone.0173810.g004){#pone.0173810.g004}

AUC differences between cGRS and wGRS were small and we found that there were no significant differences in ROC AUC for cGRS and wGRS for any of the three LMM analyses. For both cGRS and wGRS analyses, GCTA and GEMMA yielded increased ROC AUC values, when compared with PUMA. Overall, cGRS for GEMMA yielded the highest AUC at 0.9634, indicating that this algorithm is most efficient at classifying case and control status amongst GWAS dogs ([Table 3](#pone.0173810.t003){ref-type="table"}).

10.1371/journal.pone.0173810.t003

###### Receiver Operating Characteristic (ROC) analysis of genetic risk scoring in ACL rupture case and control Labrador Retriever dogs using GWAS associated SNPs from linear mixed model analysis.

![](pone.0173810.t003){#pone.0173810.t003g}

  LMM     cGRS                                          wGRS                                                           
  ------- --------------------------------------------- ---------------- --------------------------------------------- ----------------
  GCTA    0.9487                                        0.9191--0.9725   0.9464                                        0.9183--0.9694
  GEMMA   0.9634                                        0.9369--0.9824   0.9601                                        0.933--0.9801
  PUMA    0.8842[\*](#t003fn002){ref-type="table-fn"}   0.8356--0.9158   0.8909[\*](#t003fn002){ref-type="table-fn"}   0.8458--0.9263

**Note**: LMM Linear mixed models used were GCTA \[[@pone.0173810.ref033]\], GEMMA \[[@pone.0173810.ref034]\], PUMA \[[@pone.0173810.ref035]\]. AUC Area under the ROC curve. Simple risk alleles count method (cGRS) and weighted method (wGRS) \[[@pone.0173810.ref042]\].

\*Significantly different from GCTA and GEMMA (*P*\<0.005 for cGRS and *P*\<0.05 for wGRS).

GWAS pathways are enriched for carbohydrate binding proteins {#sec015}
------------------------------------------------------------

Functional annotation clustering using DAVID revealed significant enrichment of a cluster of 24 genes encoding carbohydrate binding proteins (*P*\<1.84E-07, *P*~*corr*~ = 1.21E-04) that includes aggrecan (*ACAN*), a large structural protein that stabilizes the collagen network in ligament matrix \[[@pone.0173810.ref048]\]. The majority of these proteins are c-type lectin receptors (CLRs). Enrichment of a cluster of 11 genes encoding proteins with antimicrobial activity was also found (*P*\<1.74E-04, *P*~*corr*~ = 0.02) ([Table 4](#pone.0173810.t004){ref-type="table"}), including *LBP* and *BPI* which were also present in the locus on CFA 24 that met genome-wide significance. A third cluster of 21 genes involved with nucleosome assembly was also highly significant, but enrichment was likely overinflated as 17 of 18 genes in the cluster are located in a 1Mb region surrounding a single SNP. Using INRICH, we identified enrichment for a single set of genes (*TTR*, *SLC9A5*, *SLC10A1*, *SLC37A4*, *SLC6A1*, *AQP9*. *GABRP*, *GJB1*, *KCNJ3*, *ALB*, *GABRB3*, *P2RX1*, *SLC16A2)* (*P*\<5.0E-4, *P*~*corr*~ = 0.07). This pathway primarily consists of genes encoding membrane transport proteins with a wide range of physiological functions including pH regulation, glucose homeostasis, and signal transduction.

10.1371/journal.pone.0173810.t004

###### Functional annotation clustering of genes in regions associated with anterior cruciate ligament rupture identified by GWAS in the Labrador Retriever.

![](pone.0173810.t004){#pone.0173810.t004g}

  Cluster Term               Gene          Location start-end (CanFam 3.1)
  -------------------------- ------------- ---------------------------------
  **Carbohydrate binding**                 
                             *ACAN*        [chr3:51995108--52032255]{.ul}
                             *HAPLN3*      [chr3:52033940--52037803]{.ul}
                             *NPTX2*       [chr6:10805532--10808481]{.ul}
                             *CD248*       [chr18:50991445--50997063]{.ul}
                             *CLEC17A*     [chr20:48069197--48079333]{.ul}
                             *CALR*        [chr20:49250753--49255568]{.ul}
                             *MAN2B1*      [chr20:49445696--49461722]{.ul}
                             *FCER2*       [chr20:52449871--52457459]{.ul}
                             *CLEC4G*      [chr20:52476065--52480126]{.ul}
                             *CD209*       [chr20:52516871--52521506]{.ul}
                             *KLRK1*       [chr27:35634936--35658993]{.ul}
                             *KLRD1*       [chr27:35698995--35706308]{.ul}
                             *OLR1*        [chr27:35828941--35838821]{.ul}
                             *CLEC7A*      [chr27:35864121--35867654]{.ul}
                             *CLEC9A*      [chr27:35919910--35934027]{.ul}
                             *CLEC1B*      chr27:35938182--35964350
                             *CLEC12B*     [chr27:35953661--35961617]{.ul}
                             *CLEC12A*     [chr27:36040314--36051214]{.ul}
                             *CLEC2B*      [chr27:36120649--36145641]{.ul}
                             *CD69*        [chr27:36197203--36205042]{.ul}
                             *CLEC2D*      [chr27:36274914--36301802]{.ul}
                             *KLRF1*       [chr27:36152112--36157825]{.ul}
                             *KLRB1*       [chr27:36355936--36376701]{.ul}
                             *KLRG1*       [chr27:36740984--36742709]{.ul}
                             *M6PR*        [chr27:36784859--36798029]{.ul}
  **Antimicrobial**                        
                             *DEFB132*     [chr24:20589296--20592303]{.ul}
                             *DEFB128*     [chr24:20652527--20654682]{.ul}
                             *DEFB126*     [chr24:20725869--20727386]{.ul}
                             *DEFB125*     [chr24:20743523--20757512]{.ul}
                             *DEFB118*     [chr24:20771397--20900359]{.ul}
                             *DEFB116*     [chr24:20833054--20840751]{.ul}
                             *DEFB121*     [chr24:20927258--20929346]{.ul}
                             *BPI*         [chr24:26772292--26801096]{.ul}
                             *LBP*         [chr24:26810094--26821440]{.ul}
                             *HIST1H2BG*   [chr35:24178933--24179313]{.ul}
                             *HIST1H2BC*   [chr35:24989922--25000072]{.ul}

ACL rupture in the Labrador Retriever has moderate heritability {#sec016}
---------------------------------------------------------------

Using a Bayesian method, SNP heritability and narrow sense genetic heritability of ACL rupture was estimated at 0.538 and 0.521 using SNP markers and pedigrees, respectively. After correction to the liability scale for a binary trait, these estimates were 0.493 and 0.476, respectively.

Discussion {#sec017}
==========

By undertaking a within-breed GWAS in the Labrador Retriever, we found 99 regions of association with the trait, suggesting that ACL rupture is a complex, potentially highly polygenic condition. These loci explained between 48% and 56% of the disease phenotypic variation, depending on which LMM was used for the association analysis, suggesting that inherited factors make an important contribution to the disease in the Labrador Retriever dog model. We estimated narrow sense genomic heritability to be 0.48--0.49, higher values than past estimates in the Newfoundland and Boxer breeds \[[@pone.0173810.ref025],[@pone.0173810.ref026]\].

Our studied sample of Labrador Retriever dogs represented typical features of the general population, with an approximately equal number of male and female dogs and a large majority of the dogs being neutered by castration or ovariohysterectomy, respectively. ACL rupture in dogs is an acquired condition \[[@pone.0173810.ref019],[@pone.0173810.ref030]\]. In the present study, ACL rupture cases were middle-aged dogs typically, with a mean age of 6.0 years. In dogs, loss of sex steroids through neutering is a risk factor for ACL rupture \[[@pone.0173810.ref020],[@pone.0173810.ref037]\]. In human beings, ACL rupture is predisposed to female athletes \[[@pone.0173810.ref006]\]. Knee laxity in women is lowest in the follicular phase of the menstrual cycle (low estrogen), when ACL rupture is most common \[[@pone.0173810.ref049],[@pone.0173810.ref050]\]. This suggests that the influence of sex steroid levels on ACL laxity in both species may influence accumulation of matrix damage over time and, consequently, risk of rupture.

A large majority of the risk loci discovered in this study differ from a recent GWAS in the Newfoundland breed, which identified loci predominantly on CFA 1, 3, and 33 \[[@pone.0173810.ref028]\]. Although overlap of risk loci between dog breeds needs more investigation, a different genetic architecture in different breeds suggests that this complex trait likely consists of many genetic variants that are concentrated differently in different breeds through population bottlenecks and intense selection \[[@pone.0173810.ref051]\]. A similar scenario likely summarizes the genetic basis of human ACL rupture \[[@pone.0173810.ref052]\], although GWAS of human ACL rupture has not been performed to date.

Because of the high LD within breeds of dog, risk loci often contained large numbers of genes. However, two risk loci appeared to contain rSNPs located in gene deserts in intergenic regions of the genome of \>500kb that lack annotated genes or protein-coding sequences \[[@pone.0173810.ref053]\]. Complex trait disease is caused by disturbance to biological networks, not by isolated genes or proteins. Regulatory SNPs can influence gene expression through a number of mechanisms that include the three dimensional organization of the genome, RNA splicing, transcription factor binding, DNA methylation, and long non-coding RNAs (lncRNA) \[[@pone.0173810.ref053],[@pone.0173810.ref054]\]. Investigation of SNPs associated with complex trait disease in dogs with potential regulatory function through expressed quantitative trait loci (eQTL) studies or other methods \[[@pone.0173810.ref054]\] is currently lacking.

One locus consisting of a 5kb haplotype block with one other SNP on CFA 24 met genome-wide significance in the present study. Nine genes were identified in this block with diverse physiological effects on cellular and tissue homeostasis. For example, *ACTR5* plays an important role in chromatin remodeling during transcription, DNA repair, and DNA regulation \[[@pone.0173810.ref055]\]. *DHX35* encodes an ATP-ase that plays a role in RNA splicing \[[@pone.0173810.ref056]\]. *RALBAPB* as well as *FAM83D* are both important for mitotic regulation \[[@pone.0173810.ref057],[@pone.0173810.ref058]\]. While a relationship between cellular homeostasis/proliferation and ACL rupture has not been established, it is feasible that aberrations in the genes that govern these processes could have a wide range of effects that may alter ligament tissue integrity and homeostasis. Other genes in this block include *LBP* and *BPI*, which have an important function regarding immuno-stimulatory capacity of innate immune mechanisms. Notably, our top SNP resides within *PPP1R16B*. *PPP1R16B* encodes a protein that promotes angiogenesis through inhibition of phosphatase and tensin homolog (*PTEN*) \[[@pone.0173810.ref059]\]. Angiogenesis-associated signaling is important for ligament matrix remodeling after mechanical loading, and variations in this cascade have been associated with non-contact ACL rupture risk in human beings \[[@pone.0173810.ref018]\].

To further investigate the large number of genes we identified within risk loci, we also undertook pathway analysis of our data using two different methods. Pathway analysis using DAVID revealed an association with a cluster of 24 carbohydrate-binding protein genes. The majority of these proteins were CLRs. CLRs primarily function as pattern recognition receptors; they play roles in activation or suppression of the immune response through recognition of microbial, fungal, or self molecules, including recognition of MHC class 1 \[[@pone.0173810.ref060]\]. Aberrant immune function may play a role in the pathogenesis of canine ACL rupture, as development of synovial inflammation is an early event in disease pathogenesis \[[@pone.0173810.ref061]\] and is a significant factor influencing disease progression \[[@pone.0173810.ref030]\]. Other genes in the cluster include aggrecan (*ACAN*) and hyaluronan and proteoglycan link protein 3 (*HAPLN3*), or cartilage link protein. Aggrecan is a large aggregating proteoglycan that interacts with cartilage link protein and hyaluronic acid to form stable aggregates in collagenous tissues \[[@pone.0173810.ref062]\]. Through binding to fixed charged groups, the proteoglycan aggregate maintains osmotic pressure in collagenous tissues to promote water retention. Tissue hydration is important for efficient distribution of load and for the ability of cells to accomplish repair \[[@pone.0173810.ref063]\]. Equine degenerative suspensory ligament desmitis (DSLD), a debilitating disorder of horses that leads to collagen disruption and eventual rupture of the suspensory ligament, is associated with a 15-fold increase in aggrecan content of affected ligaments \[[@pone.0173810.ref064]\]. Moreover, recent work has linked human *ACAN* rs1516797 with the risk of ACL injury in both males and females \[[@pone.0173810.ref048]\]. A separate study revealed *ACAN* gene expression is up-regulated in ACL samples from female compared to male patients that have undergone ACL repair surgery, suggesting a possible etiology for the observed sex differences among patients with ACL injury \[[@pone.0173810.ref065]\]. The precise mechanism by which *ACAN* up-regulation may lead to ligament weakening is currently unclear, though a structural change appears to be the most likely etiology \[[@pone.0173810.ref063],[@pone.0173810.ref064]\].

DAVID also revealed an association with a cluster of 11 genes encoding proteins with antimicrobial activity, including *LBP* and *BPI*, which reside within the locus that met genome-wide significance in this study. These proteins work together to bind lipopolysaccharide, aiding in host defense against gram-negative organisms. DNA from a wide variety of bacterial species has been identified in the synovium of both human and canine arthritis patients \[[@pone.0173810.ref066],[@pone.0173810.ref067]\]. While a causal link between the presence of bacterial DNA and development of arthritis has not yet been established, this information suggests that interactions between antimicrobial proteins and environmental bacteria may play a role in the pathogenesis of ACL rupture. Additionally, seven of the genes in this cluster encode beta-defensin proteins. Defensins are antibiotic peptides involved in host defense at epithelial and mesenchymal surfaces. Increased expression of beta defensins has been implicated in the pathogenesis of osteoarthritis in both human beings and mouse models \[[@pone.0173810.ref068]\].

We also tested genomic regions associated with ACL rupture for gene set enrichment using INRICH. One pathway, module 415 from the Molecular Signatures Database, was inflated. This pathway included 13 genes, most of which encode membrane transport proteins with various physiological roles. *GJBI* is a member of the large connexin family and encodes connexin 32, a gap junction protein that has been implicated in the regulation of collagen synthesis and the matrix remodeling response to mechanical loading of tendon \[[@pone.0173810.ref069],[@pone.0173810.ref070]\]. Other genes in this module are associated with central nervous system function. *SLC6A1*, *GABRP*, and *GABRB3* are all associated with GABA signaling and mutations in TTR and have been associated with sensorimotor polyneuropathy \[[@pone.0173810.ref071]\]. Previous work has suggested a role for neurological pathways in susceptibility to ACL rupture in Newfoundland dogs \[[@pone.0173810.ref028]\].

ACL rupture GRSs were calculated for each dog to determine the cumulative effect of ACL rupture-associated loci on disease risk. While previous work found that wGRS better accounted for genetic risk \[[@pone.0173810.ref042]\], our study found no difference between cGRS and wGRS for any of the LMMs used. This is consistent with the idea that the ACL rupture phenotype is associated with a large number of genetic loci with small effects. In diseases with genetic loci with large effects, wGRS would more accurately represent the cumulative effect of individual loci on genetic risk. Overall, classification capability of GRS is high, with a cGRS for GEMMA AUC of approximately 96%, indicating that we have clearly captured genetic loci that contribute to ACL rupture risk in our LMM association analysis. Additionally, the proportion of variance explained by risk SNPs was calculated separately for each algorithm. Of the three, SNPs identified by GEMMA captured the largest proportion of variance. It should be noted that these estimates for classification capability as well as phenotypic variance explained are likely inflated with regard to genomic prediction as the same data were used for SNP selection, classification capability, and variance estimation. Future work should include investigation of predictive ability by applying these methods to an independent test cohort of case and control dogs.

SNP-based and pedigree-based heritability of ACL rupture were estimated at 0.49 and 0.48, respectively, using a Bayesian method. These estimates are considerably higher than restricted maximum likelihood (REML) heritability estimates calculated for other breeds of dog \[[@pone.0173810.ref025],[@pone.0173810.ref026]\]. It is unclear whether ACL rupture is truly more heritable in the Labrador Retriever than in other breeds or if the higher value is a reflection of sampling variation or the Bayesian method used. REML estimation of heritability was attempted but the algorithm did not converge, probably because of the size or structure of the data set.

A limitation for this study is sample size. Canine GWAS for a complex trait requires approximately 100 cases and 100 controls to detect a five-fold risk allele \[[@pone.0173810.ref051]\], suggesting our study has reasonable power. Only one of 99 regions identified as associated with ACL rupture met genome-wide significance. For complex trait diseases in dogs with high population prevalence and risk alleles that have relatively small effects, larger data sets with additional dogs may be required to improve statistical power. INPower analysis of our data suggested that \>1500 dogs may be required to capture additional loci that contribute to the ACL rupture phenotype.

In conclusion, detailed analysis of the genetic risk factors involved in the initiation and progression of ACL rupture will provide a clear understanding of the genetic factors that cause disturbance to biological networks sufficient to lead to ACL rupture. Our data suggest that genetic risk of ACL rupture is influenced by multiple genomic loci with small individual additive effects. In our association study, we clearly show that ACL rupture is a highly polygenic trait. Our results suggest that biological networks that control innate immune mechanisms, aggrecan (*ACAN*) signaling, cellular proliferation, membrane transport, and/or neuronal signaling pathways should be further investigated. The genetic loci we have identified in this study will guide further dissection of genomic variants associated with the ACL rupture phenotype. Importantly, dogs have long been studied as genetic models of human disease. Here, we highlight how dogs are a genetically amenable model organism for studying orthopaedic complex trait disease and provide a model system that facilitates complex trait dissection. Genetic variants that contribute to disease risk in dogs may be investigated for their potential affect in human populations. Ultimately, insights gained from this research may also lead to novel treatments and advances in complex trait genomic prediction. An accurate genomic prediction algorithm for ACL rupture in both human beings and dogs could be used to identify at-risk subjects before rupture occurs. This information could be used to control environmental variables that are known to contribute to ACL rupture risk. It would also provide the opportunity for medical intervention. Such advances could have a large impact on human and animal health.
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